{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "Kodiak Sciences Inc.", "shortName": "KODIAK SCIENCES  DL-,0001", "regularMarketPrice": 4.257, "regularMarketChangePercent": -4.3585763, "messageBoardId": "finmb_321992085", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.67253846, "fiftyTwoWeekLow": 3.837, "fiftyTwoWeekHigh": 13.0, "earningsTimestamp": 1680034080, "earningsTimestampStart": 1683889140, "earningsTimestampEnd": 1684756800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.42000008, "fiftyTwoWeekLowChangePercent": 0.10946054, "fiftyTwoWeekRange": "3.837 - 13.0", "fiftyTwoWeekHighChange": -8.743, "epsTrailingTwelveMonths": -6.33, "epsForward": -6.01, "epsCurrentYear": -4.55, "priceEpsCurrentYear": -0.93560433, "sharesOutstanding": 52344700, "bookValue": 8.379, "fiftyDayAverage": 4.82436, "fiftyDayAverageChange": -0.5673599, "fiftyDayAverageChangePercent": -0.11760315, "twoHundredDayAverage": 7.15384, "twoHundredDayAverageChange": -2.89684, "twoHundredDayAverageChangePercent": -0.40493497, "marketCap": 222831392, "forwardPE": -0.7083194, "priceToBook": 0.50805587, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.5 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1600408800000, "priceHint": 4, "regularMarketChange": -0.19400024, "regularMarketTime": 1683892036, "regularMarketDayHigh": 4.257, "regularMarketDayRange": "4.232 - 4.257", "regularMarketDayLow": 4.232, "regularMarketVolume": 1, "regularMarketPreviousClose": 4.451, "bid": 4.204, "ask": 4.313, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 4.234, "averageDailyVolume3Month": 18, "averageDailyVolume10Day": 45, "symbol": "K27.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1200 Page Mill Road", "city": "Palo Alto", "state": "CA", "zip": "94304", "country": "United States", "phone": "(650) 281-0850", "website": "https://kodiak.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, na\u00efve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.", "fullTimeEmployees": 112, "companyOfficers": [{"maxAge": 1, "name": "Dr. Victor  Perlroth M.D.", "age": 49, "title": "Co-Founder, Chairman, CEO & Pres", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 1083676, "fmt": "1.08M", "longFmt": "1,083,676"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 2904000, "fmt": "2.9M", "longFmt": "2,904,000"}}, {"maxAge": 1, "name": "Mr. John A. Borgeson CPA, CPA, M.B.A., MBA", "age": 60, "title": "Sr. VP, CFO & Sec.", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 667521, "fmt": "667.52k", "longFmt": "667,521"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 898318, "fmt": "898.32k", "longFmt": "898,318"}}, {"maxAge": 1, "name": "Dr. Jason S. Ehrlich M.D., Ph.D.", "age": 46, "title": "Chief Medical Officer & Chief Devel. Officer", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 785816, "fmt": "785.82k", "longFmt": "785,816"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael S. Louie Ph.D.", "title": "Sr. VP of Digital Transformation & Chief Information Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Hong  Liang", "age": 50, "title": "Sr. VP of Discovery Medicine", "yearBorn": 1972, "fiscalYear": 2017, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Stephen  Raillard Ph.D.", "title": "Sr. VP of Chemical Devel. & Manufacturing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Almas  Qudrat M.Sc.", "title": "Sr. VP of Quality Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. J. Pablo Velazquez-Martin M.D.", "title": "Sr. VP of Clinical Research & Translational Medicine", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Tracy  Chien", "title": "VP & Corp. Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 2, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}